OPPILOTECH LTD

Company Registration Number:
08835326 (England and Wales)

Unaudited statutory accounts for the year ended 31 January 2025

Period of accounts

Start date: 1 February 2024

End date: 31 January 2025

OPPILOTECH LTD

Contents of the Financial Statements

for the Period Ended 31 January 2025

Directors report
Profit and loss
Balance sheet
Additional notes
Balance sheet notes

OPPILOTECH LTD

Directors' report period ended 31 January 2025

The directors present their report with the financial statements of the company for the period ended 31 January 2025

Principal activities of the company

The principal activity of the company during the year under review was that of research and development within the bioscience industry, utilising a proprietary High-Resolution Dynamic Modelling platform, in combination with specialist microbiology services, particularly in the area of antimicrobial drug development.



Directors

The directors shown below have held office during the whole of the period from
1 February 2024 to 31 January 2025

Dr J Filbey
Mr D I Ford
Dr J George
Dr A Mistry
Dr K A Powell


The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006

This report was approved by the board of directors on
16 June 2025

And signed on behalf of the board by:
Name: Dr A Mistry
Status: Director

OPPILOTECH LTD

Profit And Loss Account

for the Period Ended 31 January 2025

2025 2024


£

£
Turnover: 73,232 233,350
Cost of sales: ( 382,486 ) ( 208,580 )
Gross profit(or loss): (309,254) 24,770
Distribution costs: 0 0
Administrative expenses: ( 121,035 ) ( 127,986 )
Other operating income: 333,037 95,798
Operating profit(or loss): (97,252) (7,418)
Interest receivable and similar income: 0 0
Interest payable and similar charges: ( 27,366 ) ( 3,746 )
Profit(or loss) before tax: (124,618) (11,164)
Tax: 10,683 14,553
Profit(or loss) for the financial year: (113,935) 3,389

OPPILOTECH LTD

Balance sheet

As at 31 January 2025

Notes 2025 2024


£

£
Called up share capital not paid: 50 50
Fixed assets
Intangible assets:   0 0
Tangible assets: 3 2,544 3,073
Investments:   0 0
Total fixed assets: 2,544 3,073
Current assets
Stocks:   0 0
Debtors: 4 15,439 114,046
Cash at bank and in hand: 55,802 23,038
Investments:   0 0
Total current assets: 71,241 137,084
Prepayments and accrued income: 118,448 94,729
Creditors: amounts falling due within one year: 5 ( 278,370 ) ( 241,720 )
Net current assets (liabilities): (88,681) (9,907)
Total assets less current liabilities: (86,087) ( 6,784)
Creditors: amounts falling due after more than one year: 6 ( 9,485 ) ( 17,818 )
Provision for liabilities: 0 0
Accruals and deferred income: ( 3,384 ) ( 5,298 )
Total net assets (liabilities): (98,956) (29,900)
Capital and reserves
Called up share capital: 264 260
Share premium account: 358,100 313,225
Other reserves: 0 0
Profit and loss account: (457,320 ) (343,385 )
Total Shareholders' funds: ( 98,956 ) (29,900)

The notes form part of these financial statements

OPPILOTECH LTD

Balance sheet statements

For the year ending 31 January 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 16 June 2025
and signed on behalf of the board by:

Name: Dr J George
Status: Director

The notes form part of these financial statements

OPPILOTECH LTD

Notes to the Financial Statements

for the Period Ended 31 January 2025

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

    Turnover policy

    Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

    Tangible fixed assets depreciation policy

    Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life. Office equipment - 33% straight line basis Plant and machinery - 25% straight line basis

    Other accounting policies

    Taxation Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. Current or deferred taxation assets and liabilities are not discounted. Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date. Deferred tax Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date. Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Research and development Expenditure on research and development is written off in the year in which it is incurred. Hire purchase and leasing commitments Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease. Pension costs and other post-retirement benefits The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

OPPILOTECH LTD

Notes to the Financial Statements

for the Period Ended 31 January 2025

  • 2. Employees

    2025 2024
    Average number of employees during the period 4 4

    One of the employees did not draw a salary during the financial year nor the previous year.

OPPILOTECH LTD

Notes to the Financial Statements

for the Period Ended 31 January 2025

3. Tangible assets

Land & buildings Plant & machinery Fixtures & fittings Office equipment Motor vehicles Total
Cost £ £ £ £ £ £
At 1 February 2024 6,275 6,275
Additions 1,416 1,416
Disposals 0 0
Revaluations 0 0
Transfers 0 0
At 31 January 2025 7,691 7,691
Depreciation
At 1 February 2024 3,202 3,202
Charge for year 1,945 1,945
On disposals 0 0
Other adjustments 0 0
At 31 January 2025 5,147 5,147
Net book value
At 31 January 2025 2,544 2,544
At 31 January 2024 3,073 3,073

OPPILOTECH LTD

Notes to the Financial Statements

for the Period Ended 31 January 2025

4. Debtors

2025 2024
£ £
Trade debtors 0 70,000
Prepayments and accrued income 0 0
Other debtors 15,439 44,046
Total 15,439 114,046
Debtors due after more than one year: 0 0

OPPILOTECH LTD

Notes to the Financial Statements

for the Period Ended 31 January 2025

5. Creditors: amounts falling due within one year note

2025 2024
£ £
Bank loans and overdrafts 0 0
Amounts due under finance leases and hire purchase contracts 0 0
Trade creditors 39,973 29,313
Taxation and social security 4,275 3,693
Accruals and deferred income 0 0
Other creditors 234,122 208,714
Total 278,370 241,720

The convertible loan note, which converts to equity on a qualifying finance event or change of control. If none of these events occurred, the note was repayable on 31 December 2022, now extended to 31 December 2026 (2024: 31 December 2025). The Covid-19 Bounce Back Loan was received on 22 March 2021 for £42,750 and £9,040 (2024: £9,257) is the principal amount which is repayable before 31 Jan 2026. Interest is at 2.5%. SPRK Capital Loan 31.1.25 31.1.24 £ £ Balance at start of financial year: £106,922 Drawdowns during the financial year £242,764 £104,319 Repayments during the financial year £(234,459) - Interest and fees charged £11,729 £2,603 Balance at end of financial year: £126,956 £106,922 The SPRK Capital loan funds the spend on the project which is in part funded by the Innovate UK grant. The company draws down the quarterly spend which is the principal amount of the loan, subsequently repaid once the Innovate UK grant funds are received. Interest is charged at 16%. Fees are £499 per drawdown.

OPPILOTECH LTD

Notes to the Financial Statements

for the Period Ended 31 January 2025

6. Creditors: amounts falling due after more than one year note

2025 2024
£ £
Other creditors 9,485 17,818
Total 9,485 17,818

The Covid-19 Bounce Back Loan was received on 22 March 2022. £9,485 (2024: £ 17,818) is the principal amount falling due after 1 February 2026. The loan interest is 2.5%.The total amount outstanding as at 31.1.24 was £18,525 (2024: £ 27,025).

OPPILOTECH LTD

Notes to the Financial Statements

for the Period Ended 31 January 2025

7. Financial Commitments

The following secured debts are included within creditors: 31.1.25 31.1.24 £ £ SPRK Capital Limited 126,956 106,922 SPRK Capital Limited registered on 9 October 2023, a first legal mortgage over all land, intellectual property, copyrights (including software), patents, trademarks, trade names, service marks, business names, design and database rights, semi-conductor topography rights and any other rights which are not disposed of in the ordinary course of business. Contains floating charge over all assets of the company and negative pledge.